Edition:
United States

Boule Diagnostics AB (BOUL.ST)

BOUL.ST on Stockholm Stock Exchange

269.00SEK
9 Dec 2016
Change (% chg)

29.00kr (+12.08%)
Prev Close
240.00kr
Open
248.00kr
Day's High
269.00kr
Day's Low
248.00kr
Volume
26,836
Avg. Vol
17,640
52-wk High
269.00kr
52-wk Low
62.50kr

BOUL.ST

Chart for BOUL.ST

About

Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that... (more)
No analyst recommendations are available for BOUL.ST.

Overall

Beta: 1.01
Market Cap(Mil.): kr1,266.22
Shares Outstanding(Mil.): 4.71
Dividend: 0.60
Yield (%): 0.22

Financials

  BOUL.ST Industry Sector
P/E (TTM): 35.84 57.76 30.40
EPS (TTM): 7.51 -- --
ROI: 15.93 7.10 15.24
ROE: 17.45 10.71 16.58

BRIEF-Boule Diagnostics Q3 operating profit up at SEK 24.8 mln

* Q3 net sales 108.5 million Swedish crowns ($12 million)versus 88.8 million crowns year ago

Nov 09 2016

BRIEF-Boule Diagnostics wins assignment from Red Cross in Kenya

* Wins assignment from Red Cross in Kenya Source text for Eikon:

Oct 17 2016

BRIEF-Boule Diagnostics wins contract in USA

* Says has signed deal with Novant Health Systems in United States, as primary vendor for three part differential hematology systems

Aug 26 2016

BRIEF-Boule Diagnostics Q2 operating profit up at SEK 12.6 million

* Q2 net sales 102.0 million Swedish crowns ($11.9 million) versus 78.9 million crowns year ago

Aug 01 2016

BRIEF-Boule Diagnostics wins new major contracts in Mexico

* Instruments will be delivered in the end of Q2 and the beginning of Q3 2016 Source text: http://bit.ly/233Tnfa

Jun 13 2016

Earnings vs. Estimates